Goldman Sachs Group »

Design Therapeutics shares owned by Goldman Sachs Group

Quarter-by-quarter ownership of Design Therapeutics (DSGN) shares owned by Goldman Sachs Group from 13F filings

Historical chart of Goldman Sachs Group investment in Design Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Design Therapeutics held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Design Therapeutics by Goldman Sachs Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $2.7M 1.0M 2.65
2023-09-30 $1.0M 445k 2.36
2023-06-30 $2.8M 447k 6.30
2023-03-31 $1.7M 301k 5.77
2022-12-31 $2.8M 275k 10.26
2022-06-30 $1.3M 91k 14.00
2022-03-31 $1.9M 117k 16.15
2021-12-31 $1.5M 68k 21.39
2021-09-30 $810k 55k 14.69
2021-03-31 $2.5M 84k 29.90